Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity

Annals of Neurology

Volumn 49, Issue 1, 2001, Pages 79-89

  Lotharius, Julie ^a   O'Malley, Karen L ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Box 8108 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; FREE RADICAL; METIROSINE; RESERPINE; ROTENONE;

ANIMAL CELL; ARTICLE; BRAIN MITOCHONDRION; CELL DEATH; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL;

AMPHETAMINE; ANIMALS; CELL DEATH; CELL LINE; DOPAMINE; MICE; MITOCHONDRIA; NEURONS; OXIDATIVE STRESS;

EID: 0035109494     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200101)49:1<79::AID-ANA11>3.0.CO;2-D     Document Type: Article

References (83)

1. Neurotoxicity of methamphetamine and related drugs
2. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers
3. Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: A regional analysis in nigrostriatal and mesolimbic projections
4. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain
5. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate
6. Methamphetamine neurotoxicity involves vacuolation of endocytic organdies and dopamine-dependent intracellular oxidative stress
7. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats
8. Role of dopamine in the neurotoxic effects of methamphetamine
9. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport
10. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter
11. Treatment of mice with methamphetamine produces cell loss in the substantia nigra
12. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons
13. Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants
14. Methamphetamine induces apoptosis in immortalized neural cells: Protection by the proto-oncogene, bcl-2
15. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
16. Methamphetamine-induced neuronal damage: A possible role for free radicals
17. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: Impact of methamphetamine
18. The effects of methamphetamine on the production of free radicals and oxidative stress
19. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice
20. The free radical theory of aging matures
21. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
22. Oxy-radical toxicity in catecholamine neurons
23. Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease
24. Hydroxyl radical attack on dopamine
25. Catecholamine toxicity in cerebral cortex in dissociated cell culture
26. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture
27. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection
28. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine
29. The role of catecholamines in the action of amphetamine and L-DOPA on cerebral energy metabolism
30. Rapid ATP loss caused by methamphetamine in the mouse striatum: Relationship between energy impairment and dopaminergic neurotoxicity
31. D-amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment
32. An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
33. Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP
34. Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum
35. Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures
36. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease
37. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
38. Carboxyfullerenes as neuroprotective agents
39. Superoxide production in rat hippocampal neurons: Selective imaging with hydroethidine
40. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical
41. L-3,4-dihydroxy-phenylalanine synthesis by genetically modified Schwann cells
42. Rapid colorimetric assay for cellular growth and cytotoxicity assays
43. Carbonyl assays for determination of oxidatively modified proteins
44. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions
45. Role of oxidized amino acids in protein breakdown and stability
46. Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions
47. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines
48. Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors
49. +, but not 6-OHDA, induced cell death in a dopaminergic neuronal cell line
50. +) triggers intracellular dopamine oxidation: A novel mechanism of toxicity
51. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
52. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium
53. Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine
54. Evidence for carrier-mediated efflux of dopamine from corpus striatum
55. Interactions of [3H]amphetamine with rat brain synaptosomes: I. Saturable sequestration
56. Interactions of [3H]amphetamine with rat brain synaptosomes: II. Active transport
57. Amphetamine: Effects on catecholamine systems and behavior
58. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action
59. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons
60. Mitochondrial membrane potentional and hydroethidine-monitored superoxide generation in cultured cerebellar granule cells
61. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: Attenuation in CuZn-superoxide dismutase transgenic mice
62. Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals
63. Alpha-methyl-tyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes
64. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine
65. Effects of D-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the straitum: I. Release in the absence of vesicular transmitter stores
66. Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: A consideration of dose, core temperature and dopamine synthesis
67. Reserpine inhibits amphetamine action in ventral midbrain culture
68. Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences
69. Protein oxidation and aging
70. Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae
71. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice
72. Oxidative modification of lipids and proteins in aniline-induced splenic toxicity
73. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
74. +) cause rapid ATP depletion in isolated hepatocytes
75. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on the activities of the enzymes in the electron transport system in mouse brain
76. + on endogenous dopamine release from the rat corpus striatum superfused in vitro
77. +
78. +: Possible action at the dopamine transporter
79. +
80. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease
81. Childhood encephalopathies and myopathies: A prospective study in a defined population to assess the frequency of mitochondrial disorders
82. Mitochondrial diabetes mellitus: A review
83. Mitochondrial disorders: A diagnostic challenge in clinical chemistry